<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="172350">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00852553</url>
  </required_header>
  <id_info>
    <org_study_id>200311379</org_study_id>
    <secondary_id>200311379-8</secondary_id>
    <nct_id>NCT00852553</nct_id>
  </id_info>
  <brief_title>Neurohumoral Control of Intestinal Electrical and Mechanical Activity</brief_title>
  <official_title>Neurohumoral Control of Intestinal Electrical and Mechanical Activity</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, Davis</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of California, Davis</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A collaborative research project with Dr. Kathleen Keef (Department of Physiology,
      University of Nevada School of Medicine, Reno, Nevada) studying the role of putative
      neurotransmitters in human intestine.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Segments of intestine from patients undergoing elective gastric bypass for morbid obesity or
      resections for non-obstructive neoplasms at the UC Davis Medical Center will be used.
      Samples will be taken from tissue normally removed and sent to Pathology or discarded. Full
      thickness segments of intestine (10 mm x 1 mm) will be prepared for recording either
      intracellular electrical activity or mechanical contraction. The effects of putative
      non-adrenergic, non-cholinergic neurotransmitters (e.g., nitric oxide) will be studied. The
      source of the tissue will not be identified either directly or indirectly through
      identifiers associated with the measured responses.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2003</start_date>
  <completion_date type="Actual">February 2012</completion_date>
  <primary_completion_date type="Actual">February 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">45</enrollment>
  <condition>Morbid Obesity</condition>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      jejunum
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        All patients having elective bowel resections
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All patients having elective bowel resection

        Exclusion Criteria:

          -  Entire resected segment required for pathology

          -  Ischemic/necrotic disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Neal W. Fleming, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Professor</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of California, Davis Medical Center</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95817</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Nevada School of Medicine</name>
      <address>
        <city>Reno</city>
        <state>Nevada</state>
        <zip>89557</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2012</verification_date>
  <lastchanged_date>July 23, 2012</lastchanged_date>
  <firstreceived_date>February 26, 2009</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of California, Davis</investigator_affiliation>
    <investigator_full_name>Neal Fleming, MD, PhD</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>intestinal</keyword>
  <keyword>smooth</keyword>
  <keyword>muscle</keyword>
  <keyword>GI</keyword>
  <keyword>motility</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Obesity, Morbid</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
